Skip to main content
TEYI PHARMACEUTICAL GROUP CO.,LTD logo

TEYI PHARMACEUTICAL GROUP CO.,LTD — Investor Relations & Filings

Ticker · 002728 ISIN · CNE100001WK6 LEI · 300300ZUIZCFPGQWOZ61 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,596 across all filing types
Latest filing 2018-11-27 Governance Information
Country CN China
Listing Shenzhen Stock Exchange 002728

About TEYI PHARMACEUTICAL GROUP CO.,LTD

https://www.tczy.com.cn

TEYI PHARMACEUTICAL GROUP CO.,LTD. specializes in the research, development, manufacturing, and distribution of pharmaceutical products. The company's portfolio primarily consists of Chinese patent medicines and chemical drug preparations. Its flagship product, Zhike Bao Tablets, is widely recognized for treating chronic bronchitis and cough-related ailments. Beyond respiratory health, the group produces a diverse range of medications covering cardiovascular diseases, gastrointestinal disorders, and anti-infective treatments. Teyi Pharmaceutical operates modern production facilities and maintains a robust distribution network to serve healthcare providers and pharmacies. The company emphasizes the integration of traditional medicinal knowledge with modern pharmaceutical technology to enhance product efficacy and safety.

Recent filings

Filing Released Lang Actions
公司章程（2018年11月）
Governance Information Classification · 100% confidence The document is titled as the Articles of Association (章程) of 特一药业集团股份有限公司, which is a detailed corporate governance document outlining the company's organizational structure, shareholder rights, board and management roles, meeting procedures, share issuance and transfer rules, and other governance-related provisions. It references laws such as the Company Law and Securities Law of China, and includes detailed chapters on shareholders, board of directors, general manager, supervisory board, financial accounting, profit distribution, auditing, notices and announcements, mergers, amendments to the articles, and other governance matters. The content is not a financial report, earnings release, or announcement but a governance framework document. Therefore, it fits the category of Governance Information (CGR). The document length is substantial (15,000 characters), indicating it is the full text of the articles, not a brief announcement or summary. Hence, the classification is CGR with high confidence.
2018-11-27 Chinese
董事会议事规则（2018年11月）
Governance Information Classification · 95% confidence The document is titled '董事会议事规则' which translates to 'Rules of Procedure for the Board of Directors' of 特一药业集团股份有限公司. It details the composition, powers, meeting procedures, proposal submission, voting, and record-keeping of the company's board meetings. There is no financial data, audit results, or report content. Instead, it is a governance document outlining internal rules and board structure. This matches the description of Governance Information (CGR). The document length is over 5,000 characters and contains detailed governance rules, not just an announcement or summary. Therefore, the correct classification is CGR with high confidence.
2018-11-27 Chinese
关于召开2018年第三次临时股东大会的通知
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a detailed notice about convening the 2018 third extraordinary general meeting of shareholders for 特一药业集团股份有限公司. It includes information about the meeting time, location, agenda items (such as proposals on director and supervisor remuneration, amendments to company articles and meeting rules), voting procedures including online voting, registration details, and proxy forms. There is no financial data or results reported, nor is it a transcript or presentation. The document is an official announcement informing shareholders about the meeting and how to participate and vote. It is not the voting results or minutes, nor a report or presentation. Therefore, it fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA) best, as it relates to shareholder voting and meeting arrangements. However, since it is a notice of the meeting and voting procedures rather than the results, it is more precisely a Proxy Solicitation & Information Statement (PSI), which covers materials sent to shareholders to provide information and request votes for meetings. The document length is under 5,000 characters, but it contains detailed meeting and voting information, not just a brief announcement. Hence, the best classification is PSI.
2018-11-27 Chinese
股东大会议事规则（2018年11月）
Governance Information Classification · 95% confidence The document is titled as "股东大会议事规则" which translates to "Rules of Procedure for the Shareholders' General Meeting" of 特一药业集团股份有限公司. The content extensively details the procedures, rules, and regulations governing the conduct, convening, proposals, voting, and resolutions of shareholders' meetings. It includes references to legal compliance, voting rights, meeting notices, and the responsibilities of the board and shareholders during meetings. There is no financial data, earnings information, or report content. Instead, it is a governance document outlining internal rules and procedures related to shareholder meetings. This fits the definition of Governance Information (CGR), which covers reports detailing the company's internal rules, board structure, and governance practices.
2018-11-27 Chinese
关于完成董事会换届选举及部分董事届满离任的公告
Board/Management Information Classification · 100% confidence The document is an announcement regarding the completion of the board of directors' re-election and the departure of some directors due to term expiration. It details the election results, names of new board members, their qualifications, and the legal compliance of their appointments. There is no financial data, earnings information, or report publication mentioned. The content focuses on changes in the company's board of directors, which fits the category of Board/Management Information (MANG). The document length is 3503 characters, which is consistent with an announcement rather than a full report. Therefore, the appropriate classification is MANG.
2018-11-27 Chinese
关于聘任总经理、副总经理的公告
Board/Management Information Classification · 100% confidence The document is an announcement regarding the appointment of the company's general manager and deputy general managers. It includes details about the board meeting and the approved appointments. There is no financial data, no report or presentation content, and it relates to changes in senior management. Therefore, it fits the category of Board/Management Information (MANG). The document length is short and focused on management appointments, confirming this classification.
2018-11-27 Chinese

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.